Alps Advisors Inc Prothena Corp Public LTD CO Transaction History

Alps Advisors Inc

$15.7 Billion
Q4 2024

A detailed history of Alps Advisors Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Alps Advisors Inc holds 43,510 shares of PRTA stock, worth $538,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,510

Previous 41,627 4.52%

Holding current value

$538,653

Previous $696,000 13.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$11.95 - $18.35 $22,501 - $34,553	1,883 Added 4.52%	43,510 $602,000
Q3 2024 Nov 12, 2024	SELL	$16.73 - $24.79 $5,152 - $7,635	-308 Reduced 0.73%	41,627 $696,000
Q2 2024 Aug 13, 2024	BUY	$19.54 - $26.15 $79,058 - $105,802	4,046 Added 10.68%	41,935 $865,000
Q1 2024 May 14, 2024	BUY	$24.75 - $40.66 $33,635 - $55,256	1,359 Added 3.72%	37,889 $938,000
Q4 2023 Feb 14, 2024	SELL	$32.31 - $52.32 $96,736 - $156,646	-2,994 Reduced 7.58%	36,530 $1.33 Million
Q3 2023 Nov 14, 2023	BUY	$47.3 - $70.6 $35,380 - $52,808	748 Added 1.93%	39,524 $1.91 Million
Q2 2023 Aug 14, 2023	BUY	$48.26 - $78.59 $199,892 - $325,519	4,142 Added 11.96%	38,776 $2.65 Million
Q1 2023 May 10, 2023	BUY	$46.97 - $58.27 $87,270 - $108,265	1,858 Added 5.67%	34,634 $1.68 Million
Q4 2022 Feb 14, 2023	BUY	$52.05 - $65.0 $374,031 - $467,090	7,186 Added 28.08%	32,776 $1.97 Million
Q3 2022 Nov 14, 2022	SELL	$25.16 - $60.63 $54,848 - $132,173	-2,180 Reduced 7.85%	25,590 $1.55 Million
Q2 2022 Aug 11, 2022	SELL	$22.73 - $39.98 $459,418 - $808,075	-20,212 Reduced 42.12%	27,770 $754,000
Q1 2022 May 16, 2022	SELL	$30.27 - $49.22 $179,682 - $292,169	-5,936 Reduced 11.01%	47,982 $1.76 Million
Q4 2021 Feb 09, 2022	SELL	$42.11 - $73.26 $54,237 - $94,358	-1,288 Reduced 2.33%	53,918 $2.66 Million
Q3 2021 Nov 15, 2021	SELL	$48.2 - $78.89 $128,886 - $210,951	-2,674 Reduced 4.62%	55,206 $3.93 Million
Q2 2021 Aug 11, 2021	SELL	$21.63 - $57.65 $310,109 - $826,528	-14,337 Reduced 19.85%	57,880 $2.98 Million
Q1 2021 May 07, 2021	BUY	$11.0 - $28.24 $869 - $2,230	79 Added 0.11%	72,217 $1.81 Million
Q4 2020 Feb 03, 2021	BUY	$10.12 - $13.94 $730,036 - $1.01 Million	72,138 New	72,138 $866,000

Others Institutions Holding PRTA

# of Institutions

197

Shares Held

39.3M

Call Options Held

601K

Put Options Held

259K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $581M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Prothena Corp Public LTD CO Transaction History